In hearing impaired patients, neurophysiological measurements are becoming increasingly relevant for diagnostic work-up, therapy indication and treatment monitoring. Objective measures, so-called biomarkers, can help to assess the integrity and function of the peripheral and central auditory system. There are a range of different measurement methods and techniques used in this context. These range from electrophysiological recordings (either with conventional measuring electrodes or, in case of cochlear implant recipients, directly with the implant electrode) to advanced imaging techniques (including magnetic resonance imaging changes to alterations in light absorption when using functional near-infrared spectroscopy). We expect these biomarkers to facilitate therapeutic indication and counselling of patients as well as to provide monitoring tools during (e.g. during cochlear implant insertion) and after therapy (i.e. in the rehabilitation phase).
This special issue is dedicated to neurophysiological measurement methods that reveal the integrity and function of the peripheral and central auditory pathways. Recent advancements in biomarkers used in assessing auditory system functionality in the intra-operative, post-operative and disease-specific assessment of auditory system function.
The purpose of this Research Topic is to bring together numerous, disparate techniques & biomarkers in a full assessment of auditory system function. Biomarkers should allow an objective assessment and thus foster our understanding in this field.
Different measurement methods should be presented, which evaluate the integrity and functionality of the peripheral and central auditory pathway. Thereby, the topic should be covered as comprehensively as possible, i.e. from intracochlear signal changes to brainstem potentials to auditory cortical activations.
Three possible aspects will be included:
i) diagnostic work-up (e.g., is the auditory pathway intact?),
ii) therapy indication in hearing impaired patients (e.g., will someone benefit from a hearing aid?)
iii) treatment and rehabilitation monitoring (e.g., is the cochlear implant electrode inserted without trauma?).
Finally, the presented methods should describe objective biomarkers and not depend on subjective assessment.
In hearing impaired patients, neurophysiological measurements are becoming increasingly relevant for diagnostic work-up, therapy indication and treatment monitoring. Objective measures, so-called biomarkers, can help to assess the integrity and function of the peripheral and central auditory system. There are a range of different measurement methods and techniques used in this context. These range from electrophysiological recordings (either with conventional measuring electrodes or, in case of cochlear implant recipients, directly with the implant electrode) to advanced imaging techniques (including magnetic resonance imaging changes to alterations in light absorption when using functional near-infrared spectroscopy). We expect these biomarkers to facilitate therapeutic indication and counselling of patients as well as to provide monitoring tools during (e.g. during cochlear implant insertion) and after therapy (i.e. in the rehabilitation phase).
This special issue is dedicated to neurophysiological measurement methods that reveal the integrity and function of the peripheral and central auditory pathways. Recent advancements in biomarkers used in assessing auditory system functionality in the intra-operative, post-operative and disease-specific assessment of auditory system function.
The purpose of this Research Topic is to bring together numerous, disparate techniques & biomarkers in a full assessment of auditory system function. Biomarkers should allow an objective assessment and thus foster our understanding in this field.
Different measurement methods should be presented, which evaluate the integrity and functionality of the peripheral and central auditory pathway. Thereby, the topic should be covered as comprehensively as possible, i.e. from intracochlear signal changes to brainstem potentials to auditory cortical activations.
Three possible aspects will be included:
i) diagnostic work-up (e.g., is the auditory pathway intact?),
ii) therapy indication in hearing impaired patients (e.g., will someone benefit from a hearing aid?)
iii) treatment and rehabilitation monitoring (e.g., is the cochlear implant electrode inserted without trauma?).
Finally, the presented methods should describe objective biomarkers and not depend on subjective assessment.
